首页 > 市场调查报告书 > 工业机械

市场调查报告书

商品编码

1846029

终端灭菌服务市场（按灭菌方法、最终用户、应用和地区划分），2024 年至 2031 年

Terminal Sterilization Services Market By Sterilization Method, End-User, Application, & Region for 2024-2031

出版日期: 2025年08月16日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

终端灭菌服务市场评估 - 2024-2031

由于医疗保健和製药业对安全有效的灭菌需求日益增长，对终端灭菌服务的需求也日益高涨。终端灭菌是指在物品（尤其是医疗设备、药品和包装）密封于最终容器后对其进行灭菌的过程。这确保了物品中不存在活菌，使其适合使用或消费。这推动了终端灭菌市场在2023年的收益超过119.6亿美元，并在2031年达到约269.6亿美元的估值。

随着人们对感染疾病的认识不断提高，监管标准也日益严格，加上製药和医疗设备产业的扩张，对终端灭菌服务的需求不断增长。这些服务在确保医疗用品的安全性和有效性方面日益重要，增强了其在公共卫生领域的重要作用，推动了市场在2024年至2031年期间的复合年增长率达到10.70%。

终端灭菌服务市场定义/概要

终端灭菌服务是指对医疗设备、药品和其他医疗保健产品在其最终包装内进行灭菌的过程。此程序可彻底清除或惰性细菌、病毒和真菌等危险微生物，确保产品安全使用。终端灭菌是医疗用品（例如手术器械、植入和静脉输液）生产过程中不可或缺的一步。之所以称为“终端”，是因为该过程在产品完全包装和密封后进行，确保内容物在开封使用前保持无菌状态。

终端灭菌服务对于确保各种产品的安全性和有效性至关重要，尤其是在医疗和製药行业。其主要应用之一是医疗设备器械的灭菌。从手术器械到植入，这些产品在用于医疗机构之前必须无微生物污染。终端灭菌需要对这些器械进行严格的灭菌处理，例如高温灭菌、辐射灭菌和化学灭菌，以消灭所有形式的微生物，包括细菌、病毒和孢子。

随着医疗保健和製药行业的蓬勃发展以及患者安全日益成为优先事项，终端灭菌服务的使用预计将在未来大幅增长。终端灭菌是对最终包装产品进行灭菌的过程，旨在确保医疗设备、药品和其他医疗保健用品在送达患者之前不含有害细菌。

日益增长的灭菌服务需求是否会推动终端灭菌服务市场的发展？

由于医疗保健和製药等各行各业对灭菌服务的需求不断增长，预计终端灭菌服务市场将显着增长。其中一个主要因素是全球外科手术数量的不断增加。根据世界卫生组织 (WHO) 统计，全球每年进行超过 2.34 亿例大型手术。大量的手术需要严格的灭菌技术，以避免医院相关感染 (HAI)。根据美国疾病管制与预防中心 (CDC) 的数据，大约每 31 名住院患者中就有 1 名每天至少经历一次 HAI，这凸显了对适当灭菌服务的迫切需求。

製药和生物技术产业的成长也是关键驱动因素，这些产业需要无菌生产设施和产品灭菌。 IQVIA人类数据科学研究所预测，到2023年，全球医药市场规模将达到1.5兆美元。同时，产品安全和品质监管法规的加强也促进了这一成长。例如，美国食品药物管理局（FDA）已实施更为严格的无菌药品生产规定，详见其2018年灭菌技术指引草案。此外，新冠疫情提高了人们对灭菌在限制疾病传播方面必要性的认识，从而加速了市场成长。

任务的复杂性是否会阻碍终端灭菌服务市场的发展？

终端灭菌服务的操作复杂性是市场拓展的一大障碍。终端灭菌程序需要严格控制各种因素，包括温度、压力、时间和湿度，这些因素很难在不同产品类型和批次之间保持一致。世界卫生组织 (WHO) 的一项调查显示，近 10% 的医疗设备因操作困难而无法完成灭菌流程，导致潜在的安全问题和成本增加。美国食品药物管理局(FDA) 声称，2015 年至 2020 年间，因灭菌失败而召回的产品超过 200 起，凸显了维持无菌保证标准的难度。

此外，医疗设备和药品所用材料的日益多样化也增加了这项任务的复杂性。《医院感染杂誌》发表的一项研究发现，大约30%的医疗机构难以确定适用于创新材料或先进器械设计的可接受灭菌方法。欧洲药品管理局 (EMA) 预测，检验新材料的灭菌技术可能需要长达18个月的时间，这可能会延迟产品的上市和上市时间。此外，FDA和EMA等机构施加的严格监管要求涉及大量的文件和验证流程，这可能需要大量的时间和资源。根据国际医疗中央服务材料管理协会 (IAHCSMM) 进行的一项民意调查，65%的灭菌专业人士认为合规性是一个重大问题。

Terminal sterilization services are in high demand owing to the growing need for safe and effective sterilization in the healthcare and pharmaceutical industries. Terminal sterilization is the process of sterilizing things, specifically medical equipment, pharmaceuticals, and packaging, after they have been sealed in their final containers. This guarantees that the items are free of live bacteria, making them suitable for use or ingestion by enabling the market to surpass a revenue of USD 11.96 Billion valued in 2023 and reach a valuation of around USD 26.96 Billion by 2031.

The growing awareness of infection hazards demanding regulatory standards, and the expansion of the pharmaceutical and medical device industries are all driving up demand for terminal sterilization services. These services are becoming increasingly important in ensuring the safety and efficacy of healthcare items reinforcing their key role in public health by enabling the market to grow at a CAGR of 10.70% from 2024 to 2031.

Terminal Sterilization Services Market: Definition/ Overview

Terminal sterilization services refer to the process of sterilizing medical devices, medicines, and other healthcare products in their final packaging. This procedure ensures that any dangerous microorganisms such as bacteria, viruses, and fungi are fully removed or inactivated, rendering the product safe to use. Terminal sterilization is an essential stage in the manufacturing of medical supplies such as surgical equipment, implants, and intravenous fluids. It's named ""terminal"" because it happens after the product has been entirely packaged and sealed guaranteeing that the contents are sterile until they're opened for usage.

Terminal sterilization services are critical to guaranteeing the safety and efficacy of diverse products, especially in the medical and pharmaceutical industries. One of the principal applications is to sterilize medical devices and tools. These goods which range from surgical equipment to implants must be free of microbiological contamination before they may be used in healthcare facilities. Terminal sterilization requires subjecting these devices to harsh sterilization techniques such as heat, radiation, or chemical sterilization to destroy all forms of microbiological life including bacteria, viruses, and spores.

The future use of terminal sterilization services is expected to increase significantly as the healthcare and pharmaceutical industries expand and prioritize patient safety. Terminal sterilization, or the process of sterilizing products in their final packaging ensures that medical equipment, medications, and other healthcare supplies are free of hazardous bacteria before reaching patients.

Will the Growing Need for Sterilization Services Drive the Terminal Sterilization Services Market?

The Terminal Sterilization Services Market is predicted to develop significantly due to increased demand for sterilization services in a variety of industries including healthcare and pharmaceutical. One of the key factors is the increasing number of surgical procedures performed worldwide. According to the World Health Organization (WHO), over 234 million major surgical procedures are conducted globally each year. To avoid healthcare-associated infections (HAIs), strict sterilization techniques are required due to the high volume of surgeries. According to the Centers for Disease Control and Prevention (CDC), approximately one in every 31 hospital patients experiences at least one HAI on any given day emphasizing the crucial need for adequate sterilization services.

Another significant driver is the growing pharmaceutical and biotechnology industries which require sterile manufacturing facilities and product sterilization. The IQVIA Institute for Human Data Science estimates that the global pharmaceutical market will be worth USD 1.5 Trillion by 2023. This expansion is complemented by tougher regulations governing product safety and quality. For example, the United States Food and Medicine Administration (FDA) has introduced more stringent rules for sterile medicine manufacture, as detailed in its 2018 draft guidance on sterilization techniques. Furthermore, the COVID-19 pandemic has raised awareness of the necessity of sterilization in limiting disease transmission accelerating market growth.

Will the Complexity of Operations Hamper the Terminal Sterilization Services Market?

The intricacy of operations in terminal sterilization services is a significant barrier to market expansion. Terminal sterilization procedures necessitate careful control over a variety of factors such as temperature, pressure, time, and humidity which can be difficult to maintain consistently between product kinds and batches. According to World Health Organization (WHO) research almost 10% of medical equipment fail sterilization processes due to operational difficulties posing possible safety issues and increasing expenses. The Food and Drug Administration (FDA) claimed that between 2015 and 2020, there were over 200 recalls due to sterilization failures emphasizing the difficulties associated with maintaining sterility assurance standards.

Furthermore, the increasing diversity of materials used in medical devices and medications adds to operational complexity. A study published in the Journal of Hospital Infection discovered that approximately 30% of healthcare facilities had difficulty identifying acceptable sterilization methods for innovative materials and sophisticated device designs. The European Medicines Agency (EMA) predicts that validating sterilization techniques for new materials might take up to 18 months possibly delaying product launches and market entrance. Furthermore, the strict regulatory requirements imposed by organizations such as the FDA and EMA involve substantial documentation and validation processes which can be time-consuming and resource-intensive. According to a poll conducted by the International Association for Healthcare Central Service Materiel Management (IAHCSMM), 65% of sterilization specialists see regulatory compliance as a significant concern.

Category-Wise Acumens

Will Innovation in Sterilization Techniques Influence the Application Segment?

The medical devices market is expected to dominate the market over the forecast period . This dominance stems from the important necessity to ensure that medical items such as surgical tools, implants, and diagnostic equipment are clear of any microbial contamination before being used in medical procedures. To ensure patient safety and avoid healthcare-associated infections, health authorities such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strong regulatory requirements and standards on sterilizing operations. As the complexity and variety of medical equipment evolve, there is a growing demand for specialist sterilization services capable of handling various materials and intricate designs.

The medical devices segment benefits from constant innovation in sterilizing processes that are tailored precisely to the specialized needs of medical equipment. For example, the increased use of minimally invasive surgical equipment and advanced implants needs sterilization technologies that can provide complete disinfection without risking the device's integrity or operation. To address these needs, sterilization service providers are investing in cutting-edge technology like ethylene oxide (ETO), gamma irradiation, and electron beam sterilization. The emphasis on maintaining the highest levels of hygiene and sterility in healthcare settings, combined with the ongoing introduction of new and advanced medical devices, assures that this segment will continue to drive expansion in the Terminal Sterilization Services Market.

Will Versatility and Effectiveness Drive Growth in the Sterilization Method Segment?

Ethylene Oxide (ETO) sterilization is the most used procedure. This dominance stems partly from its versatility and efficacy in sterilizing a wide range of materials particularly those susceptible to heat and moisture. ETO sterilization is commonly used for medical devices, surgical instruments, and other healthcare products that cannot tolerate the high heat and moisture found in conventional sterilizing procedures such as steam. Its ability to penetrate intricate gadgets and packaging without destroying the materials makes it a popular choice among manufacturers. Furthermore, ETO sterilization is efficient against a wide range of pathogens including bacteria, viruses, and fungi, providing the maximum level of sterility for vital medical products.

This broad efficacy combined with its compatibility with a wide range of materials strengthens its market leadership. The prevalence of ETO sterilization is reinforced by its widespread use in the healthcare business which is heavily regulated and demands stringent sterilizing requirements. Despite worries about the environmental and safety dangers associated with ETO gas such as potential carcinogenic consequences, the technology is nevertheless commonly employed since alternative sterilizing procedures cannot yet match its efficacy and material compatibility. Gamma and electron beam sterilization are becoming increasingly popular particularly for specific applications such as pharmaceuticals and single-use medical devices but they are frequently limited by equipment size, material compatibility, and the requirement for specialist facilities. ETO's established infrastructure, regulatory approval, and broad applicability ensure that it remains the most popular sterilization technology in the Terminal Sterilization Services Market.

Country/Region-wise Acumens

Will the Advanced Healthcare Infrastructures Drive the Growth in the North American Region?

North America, notably the United States dominates the Terminal Sterilization Services Market owing to its modern healthcare infrastructure and strong regulatory standards. This domination is projected to persist for the foreseeable future. Advanced healthcare infrastructures in North America are fueling growth in the Terminal Sterilization Services Market. The American Hospital Association estimates that there will be 6,093 hospitals in the United States by 2022 resulting in a high need for sterilization services. According to the Centers for Disease Control and Prevention (CDC), nearly one in every 31 hospital patients contracts at least one healthcare-associated infection on any given day underlining the crucial need for proper sterilization.

According to SelectUSA, a government program in the United States, the North American medical equipment market, a significant driver for sterilization services will be worth USD 203.9 Billion by 2022. However, growing concerns about ethylene oxide (EtO) sterilization may act as a market restraint. The Environmental Protection Agency (EPA) has classified it as a carcinogen, and numerous states have imposed or proposed limitations on its use. For example, Illinois approved legislation in 2019 limiting ETO emissions from sterilizing facilities. This regulatory pressure may drive some sterilization service providers to invest in other technologies or encounter operational issues that might influence market growth.

Will the Growing Demand For Reusable Medical Devices Boost the Market in the Asia Pacific Region?

The growing need for reusable medical devices is predicted to greatly enhance the market in Asia Pacific which is projected to be one of the world's fastest-growing marketplaces. This rise in demand is being driven by numerous factors specific to the region including rapid expansion of healthcare infrastructure, an increasing burden of chronic diseases, and rising cost pressures on healthcare systems. Reusable medical devices such as surgical tools, endoscopes, and some diagnostic equipment are cost-effective options for healthcare providers because they can be sterilized and reused. This is especially relevant in the Asia Pacific where many country's healthcare systems are under pressure to deliver high-quality care to a growing population while keeping costs under control.

The Asia-Pacific region is undergoing significant economic growth which has resulted in increasing healthcare spending and facility construction. Countries such as China and India are making significant investments in their healthcare systems to fulfill the demands of their vast populations. As these countries continue to create and modernize their healthcare infrastructure, there is an increasing demand for long-lasting, low-cost medical devices. The region also benefits from a robust industrial base particularly in China, a major producer of medical gadgets. This local production capability contributes to lower prices and greater availability of reusable medical devices.

Competitive Landscape

The Terminal Sterilization Services Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the Terminal Sterilization Services Market.

STERIS, 3M, Getinge, ASP (Fortive), Belimed, Inc. (Metall Zug Group), Sterigenics U.S., LLC - A Sotera Health Company, Fedegari Autoclavi S.p.A., Olympus Corporation, Andersen Sterilizers, Steelco S.p.A.

Latest Developments

In January 2021, STERIS plc agreed to buy Cantel Medical, a provider of infection prevention services and products, through its U.S. subsidiary for about USD 4.6 billion in cash. With this acquisition, the business hoped to provide a diverse variety of infection control and procedural goods and services. Such tactics assist businesses in strengthening their global footprint.

1. Introduction

Market Definition
Market Segmentation
Research Methodology

2. Executive Summary

Key Findings
Market Overview
Market Highlights

3. Market Overview

Market Size and Growth Potential
Market Trends
Market Drivers
Market Restraints
Market Opportunities
Porter's Five Forces Analysis

4. Terminal Sterilization Services Market, By Sterilization Method

Ethylene Oxide Sterilization
Gamma Sterilization
Electron Beam Sterilization

5 Terminal Sterilization Services Market, By Application

Medical Devices
Pharmaceuticals
Lab Equipment

6 Terminal Sterilization Services Market, By End User

Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers

7. Regional Analysis

North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Asia-Pacific
China
Japan
India
Australia
Latin America
Brazil
Argentina
Chile
Middle East and Africa
South Africa
Saudi Arabia
UAE

8. Market Dynamics

Market Drivers
Market Restraints
Market Opportunities
Impact of COVID-19 on the Market

9. Competitive Landscape

Key Players
Market Share Analysis

10. Company Profiles

BASF SE
Songwon
Clariant AG
Solvay S.A.
Adeka Corporation
Addivant
Milliken Chemical
Everlight Chemical Industrial Co.

11. Market Outlook and Opportunities

Emerging Technologies
Future Market Trends
Investment Opportunities

12. Appendix

List of Abbreviations
Sources and References

02-2729-4219

+886-2-2729-4219

License/价格

终端灭菌服务市场（按灭菌方法、最终用户、应用和地区划分），2024 年至 2031 年

Terminal Sterilization Services Market By Sterilization Method, End-User, Application, & Region for 2024-2031

终端灭菌服务市场评估 - 2024-2031

日益增长的灭菌服务需求是否会推动终端灭菌服务市场的发展？

任务的复杂性是否会阻碍终端灭菌服务市场的发展？

目录

第一章 引言

第二章执行摘要

第三章 市场概况

第四章终端灭菌服务市场（依灭菌方法）

5. 终端灭菌服务市场（依应用）

6. 终端灭菌服务市场（依最终用户）

第七章区域分析

第八章市场动态

第九章 竞争态势

第十章：公司简介

第十一章 市场展望与机会

第十二章 附录

Terminal Sterilization Services Market Valuation - 2024-2031